NASDAQ:AKTX | Free Cash Flow | Akari Therapeutics Plc

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2011-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$2.49M
2025-12-31-$3.04M
2025-03-31-$2.15M
2024-12-31-$2.12M
2024-03-31-$4.04M
2023-12-31-$4.41M
2023-03-31-$4.88M
2020-12-31-$4.23M
2019-12-31-$3.46M
2016-03-31-$7.44M$42,083.00-$7.48M
2015-12-31-$6.77M
2015-03-31-$1.99M$0.00-$1.99M
2014-12-31-$667,978.00
2014-03-31-$2.05M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$10.57M
2024-12-31-$12.55M
2023-12-31-$16.43M
2022-12-31-$21.5M
2021-12-31-$18.85M
2020-12-31-$16.95M
2019-12-31-$12.92M$0.00-$12.92M
2018-12-31-$22.77M$0.00-$22.77M
2017-12-31-$31.6M$36,885.00-$31.64M
2016-12-31-$24.62M$54,750.00-$24.68M
2015-12-31-$4.97M$10,560.00-$4.98M
2014-12-31-$1.48M$0.00-$1.48M
2013-12-31-$5.45M$0.00-$5.45M
2012-12-31-$2.13M$0.00-$2.13M
2011-12-31-$1.01M$0.00-$1.01M